Breaking News

Thermo Fisher Expands NY Cell Culture Media Manufacturing Site

$76 million investment in Grand Island site increases capacity for raw materials used in the development and manufacturing of vaccines and biologic therapies.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

To meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics, Thermo Fisher Scientific has expanded its dry powder media manufacturing facility in Grand Island, NY. With this expansion, the Grand Island site provides redundant capacity to support global supply of media and further extends the site’s capabilities to produce the high-quality technology and materials needed for the development and commercial manufacturing of vaccines and biologic t...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters